GeneDx Holdings (WGS) Asset Utilization Ratio (2020 - 2026)
GeneDx Holdings' (WGS) quarterly Asset Utilization Ratio came in at 0.92 in Q2 2026, up 15.58% year-over-year from 0.8 in Q2 2025, and up 7.04% quarter-over-quarter from 0.86 in Q1 2026.
Analysis
GeneDx Holdings (WGS) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Asset Utilization Ratio for 7 consecutive years, with 0.92 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio rose 15.58% year-over-year to 0.92 in Q2 2026; TTM through Jun 2026 was 0.92, a 15.58% increase from a year earlier, with the FY2025 full-year figure at 0.91, up 24.39% from the prior year.
- Asset Utilization Ratio was 0.92 for Q2 2026 at GeneDx Holdings, up from 0.86 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.92 in Q2 2026 and troughed at 0.26 in Q3 2022.
- A 5-year average of 0.59 and a median of 0.58 in 2024 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio sank 75.68% in 2022 and soared 76.17% in 2023, its largest moves.
- Over 5 years, Asset Utilization Ratio stood at 0.36 in 2022, then jumped by 36.26% to 0.48 in 2023, then soared by 52.21% to 0.74 in 2024, then increased by 13.92% to 0.84 in 2025, then advanced by 9.5% to 0.92 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.92 (Q2 2026), 0.86 (Q1 2026), and 0.84 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 1.03 |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 0.69 |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 0.76 |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 0.62 |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 0.64 |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 0.83 |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 0.37 |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 0.56 |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 0.54 |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | 0.92 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.92 |
| Mar 31, 2026 | 0.86 |
| Dec 31, 2025 | 0.84 |
| Sep 30, 2025 | 0.84 |
| Jun 30, 2025 | 0.80 |
| Mar 31, 2025 | 0.76 |
| Dec 31, 2024 | 0.74 |
| Sep 30, 2024 | 0.67 |
| Jun 30, 2024 | 0.62 |
| Mar 31, 2024 | 0.55 |
| Dec 31, 2023 | 0.48 |
| Sep 30, 2023 | 0.46 |
| Jun 30, 2023 | 0.46 |
| Mar 31, 2023 | 0.43 |
| Dec 31, 2022 | 0.36 |
| Sep 30, 2022 | 0.26 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.38 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | 0.56 |